Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chrono-chemotherapy versus conventional cisplatin chemoradiotherapy after induction chemotherapy for locally advanced nasopharyngeal carcinoma
ChiCTR-TRC-14004607Phase 2Completed
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Tumor Hospital Affiliated to Guizhou Medical University. Primary endpoints: Toxicity and Curative effect. Started Jun 2014; status: completed.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-TRC-14004607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004607.